University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
NCT Number: NCT04637295
To examine perceptions and determinants of physical activity during the COVID-19 pandemic among cancer survivors.
Looking for future studies?
Notify Me19 year and older
All sexes
Observational
Omaha, Nebraska, 68198, United States
This purpose of this study is to examine perceptions and determinants of physical activity during the COVID-19 pandemic in cancer survivors. To test our aim, we will recruit up to 1000 adults diagnosed with cancer within the last five years and ask them to complete an online questionnaire battery assessing their self-reported physical activity habits, psychosocial outcomes (e.g., depression, anxiety, self-efficacy, social support), and perceptions of physical activity engagement during the pandemic. A subsample of participants (n=50) will also be invited to participate in an interview to gain further insights into cancer survivors' physical activity experiences during COVID-19. Analysis of covariance (ANCOVA) will be used to analyze the quantitative survey data, and thematic analysis will be used to analyze the qualitative interview data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 14 days
Godin Leisure-Time Exercise Questionnaire
Time frame: 14 days
COVID-19 Pandemic Psychosocial Functioning Measure
Time frame: 14 days
The Exercise Self-efficacy Scale will be used to measure confidence in ability to exercise. A higher score indicated a higher confidence.
Time frame: 14 days
The Pittsburgh Sleep Quality Index will be used to measure sleep quality and disturbances. A higher score indicates a higher sleep disturbance.
Time frame: 14 days
The Functional Assessment in Chronic Illness Therapy - Fatigue (FACIT-F) will be used to measure fatigue as well. Higher scores indicate less fatigue.
Time frame: 14 days
The Hospital Anxiety and Depression Scale (HADS) will be used to produce an anxiety score. Higher scores indicate higher symptoms of anxiety.
Time frame: 14 days
The Hospital Anxiety and Depression Scale (HADS) will be used to produce an anxiety score. Higher scores indicate higher symptoms of depression.
Time frame: 14 days
The UCLA Loneliness Scale will be used to measure feelings of loneliness and isolation. Higher scores indicate higher degrees of loneliness.
Time frame: 14 days
The Rosenberg Self-Esteem Scale (RSE) will be used to measure global self-esteem. Items are used to calculate an esteem score, higher scores are indicative of higher esteem.
Time frame: 14 days
The Functional Assessment in Cancer Therapy- Cognition (FACT-Cog) measures levels of cognitive impairment, quality of life and perceived cognitive ability. Items are summed up to calculate scores from each subsection.
Time frame: 14 days
The Social Support of Exercise scale is aimed to assess the degree in which family and friends demonstrate support for exercise behavior. Higher scores indicate a higher level of support.
Time frame: 14 days
The Satisfaction of Life Scale (SWLS) is developed to assess global satisfaction is various age groups.
Time frame: 14 days
The Perceived Stress Scale is a 10-item scale developed to measure the perceptions of a person's stress.
Time frame: up to one month after enrollment
A qualitative interview will be performed to measure the perceptions and barriers of exercise during the COVID-19 pandemic. This interview is comprised of items designed by the research team.
University of Nebraska
Other
Acronym: PEACE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04616846
COVID-19, Cardiovascular Diseases
Cagnes-sur-Mer, Alpes-Maritimes, France
View Trial DetailsNCT04600206
Carcinoma, Mental Disorders
Hamburg, Free and Hanseatic City of Hamburg, Germany
View Trial DetailsNCT04728334
Neoplasms, Neoplasms Malignant
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04047290
Neoplasms, Neoplasms Malignant
Albury, New South Wales, Australia
View Trial Details